Perrigo Co. Plc is a pure-play self-care company provider of consumer self-care products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. The company is headquartered in Dublin, Dublin. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. The company primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.
Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenus
4,253
4,253
4,373
4,655
4,451
4,138
Croissance des revenus (H/H)
-3%
-3%
-6%
5%
8%
1%
Coût des ventes
2,758
2,758
2,830
2,975
2,996
2,722
Bénéfice brut
1,494
1,494
1,542
1,680
1,455
1,416
Vente, Général et Administration
1,055
1,055
1,112
1,274
1,163
1,070
Recherche et développement
95
95
112
122
123
122
Frais d'exploitation
1,181
1,181
1,230
1,396
1,289
775
Autres revenus (charges) non opérationnels
-12
20
2
12
-51
-23
Bénéfice avant impôts
-1,297
-1,297
-80
-8
-139
258
Charge d'impôt sur le revenu
104
104
80
-3
-8
389
Bénéfice net
-1,425
-1,425
-171
-12
-140
-68
Croissance du bénéfice net
733%
733%
1,325%
-91%
106%
-57.99%
Actions en circulation (diluées)
137.6
138.5
137.4
135.3
134.5
133.6
Variation des actions (H-H)
0%
1%
2%
1%
1%
-2%
EPS (dilué)
-10.35
-10.29
-1.25
-0.09
-1.04
-0.51
Croissance du EPS
735%
723%
1,289%
-91%
104%
-56.99%
Flux de trésorerie libre
145
145
244
303
210
-66
Flux de trésorerie libre par action
--
--
--
--
--
--
Marge brute
35.12%
35.12%
35.26%
36.09%
32.68%
34.21%
Marge opérationnelle
7.33%
7.33%
7.11%
6.1%
3.72%
15.49%
Marge bénéficiaire
-33.5%
-33.5%
-3.91%
-0.25%
-3.14%
-1.64%
Marge du flux de trésorerie libre
3.4%
3.4%
5.57%
6.5%
4.71%
-1.59%
EBITDA
649
649
636
643
504
953
Marge EBITDA
15.25%
15.25%
14.54%
13.81%
11.32%
23.03%
D&A pour le résultat opérationnel
337
337
325
359
338
312
EBIT
312
312
311
284
166
641
Marge EBIT
7.33%
7.33%
7.11%
6.1%
3.72%
15.49%
Taux d'imposition effectif
-8.01%
-8.01%
-100%
37.5%
5.75%
150.77%
Follow-Up Questions
Perrigo Company PLC의 주요 재무제표는 무엇인가요?
최신 재무제표(Form-10K)에 따르면, Perrigo Company PLC의 총 자산은 $8,535이며, 순perte입니다.
PRGO의 주요 재무 비율은 무엇인가요?
Perrigo Company PLC의 유동비율은 1.52이고, 순이익률은 -33.5, 주당 매출은 $30.7입니다.
Perrigo Company PLC의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Le segment de revenus le plus important est Perrigo Company PLC, avec un chiffre d'affaires de Consumer Self-Care Americas lors du dernier rapport de résultats. En termes géographiques, United States est le marché principal pour Perrigo Company PLC, avec un chiffre d'affaires de 2,649,300,000.
Perrigo Company PLC은 수익성이 있나요?
non, 최신 재무제표에 따르면 Perrigo Company PLC의 순perte은 $-1,425입니다.